personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the December issue. Upfront explores Brexit and the UK’s current Withdrawal Agreement woes, transdermal patches for drug delivery, and the exploitation of CRISPR technology to modify embryonic genomes. Giovanni Appendino explains why we should tap into the medical potential of cannabis in “In My View,” while our cover feature highlights the most innovative technologies of the past year with our Innovation Awards. And Gavin Yamey discusses how a new financial modelling tool can help bridge the funding gap for neglected diseases in “Business.” In our latest Sitting Down With… Stanley Crooke, CEO at Ionis Pharmaceuticals argues that weathering the storm when creating new platforms can lead to positive outcomes.